About
TechCare has developed a platform that utilizes the vaporization of natural plant-based compounds for hair-care products. The companys proprietary formula is designed to fortify, revitalize, and nourish hair, and also has antimicrobial properties that can kill bacteria, fungus, and lice. TechCares capsules contain an organic plant-based solution with no added chemicals. The formula contained in the capsules is broken down into microparticles that penetrate deeply and evenly into every part of the hair. TechCare was created through a merger of BreedIT and Novomic in October 2016. Following the merger, Novomic has become a subsidiary of TechCare. In January 2020, Citrine Global Corporation has acquired control of the company.
Funding history · 1 round · $1.8M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is TechCare's primary business?
- TechCare develops a platform that uses the vaporization of natural plant-based compounds for hair-care products, including formulas designed to fortify, revitalize, nourish hair, and provide antimicrobial properties.
- When was TechCare founded and how was it formed?
- TechCare was founded in October 2010 and was created through a merger of BreedIT and Novomic in October 2016, with Novomic becoming a subsidiary.
- What was a significant financing event for TechCare?
- In January 2018, TechCare closed an undisclosed funding round totaling $1.8 million, with investors including Zach Rubin and Ran Tuttnauer. More details are available on startupim.
- What is TechCare's current operational status?
- TechCare is currently inactive, having been acquired by Citrine Global in January 2020.
- When did TechCare become a publicly traded company?
- TechCare had an IPO in October 2016, listing on the OTC exchange under the ticker TECR.
- What was a key product launch for TechCare in Israel?
- In May 2018, TechCare launched its Novokid lice treatment product line in Super Pharm, Israel's largest drugstore chain.
- Did TechCare expand into the Asian market?
- In January 2019, TechCare entered into a joint venture contract with China-Israel Biological Technology Co. Ltd. (CIB) to develop products for the Asian market.
- Who was appointed as the CEO of Novomic, a TechCare subsidiary?
- In January 2019, TechCare appointed Osnat Philipp, formerly an executive at Lumenis, P&G, and Teva Pharmaceuticals, as the Chief Executive Officer of Novomic.
- What regulatory approval did TechCare receive for its Novokid device?
- In August 2017, TechCare received CE Mark approval for its Novokid lice treatment device.